EIGER completed a reverse merger into publicly-traded Celladon on March 22 and concluded a concurrent $39.5 million capital raise. On August 18th ... ...read more
Growth Capitalist (https://growthcapitalist.com/2016/10/eiger-a-small-cap-biotech-with-a-billion-dollar-hepatitis-drug/)
EIGER completed a reverse merger into publicly-traded Celladon on March 22 and concluded a concurrent $39.5 million capital raise. On August 18th ... ...read more